Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Antibodies”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01403792
What this trial is testing

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Who this might be right for
Human Immunodeficiency Virus
University of Surrey 11
Early research (Phase 1)Study completedNCT02960581
What this trial is testing

Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV Infection
International AIDS Vaccine Initiative 48
Testing effectiveness (Phase 2)Ended earlyNCT03787095
What this trial is testing

Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Study completedNCT02716675
What this trial is testing

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,699
Testing effectiveness (Phase 2)Looking for participantsNCT04319367
What this trial is testing

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Who this might be right for
HIV/AIDS and Infections
Imperial College London 72
Early research (Phase 1)Study completedNCT00000904
What this trial is testing

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT04711265
What this trial is testing

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Who this might be right for
HPV VaccineHPV InfectionHIV-1-infection
Kenya Medical Research Institute 176
Not applicableStudy completedNCT00031109
What this trial is testing

The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)WithdrawnNCT02657447
What this trial is testing

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Who this might be right for
Non-Hodgkin Lymphoma
Nordic Nanovector
Large-scale testing (Phase 3)Study completedNCT00000135
What this trial is testing

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)

Who this might be right for
HIV InfectionsCytomegalovirus Retinitis
Johns Hopkins Bloomberg School of Public Health 209
Early research (Phase 1)Ended earlyNCT03705169
What this trial is testing

Pharmacokinetics and Safety of SAR441236

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Large-scale testing (Phase 3)Study completedNCT00514605
What this trial is testing

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

Who this might be right for
HIV Infections
bioLytical Laboratories 2,500
Early research (Phase 1)Study completedNCT00917813
What this trial is testing

Anti-HIV Monoclonal Antibody KD-247

Who this might be right for
HIV Infections
The Chemo-Sero-Therapeutic Research Institute 27
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Early research (Phase 1)Study completedNCT03803605
What this trial is testing

Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 15
Testing effectiveness (Phase 2)Looking for participantsNCT05719441
What this trial is testing

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Who this might be right for
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT00002286
What this trial is testing

Retrovir in the Treatment of Psoriasis in HIV-Positive Patients

Who this might be right for
HIV InfectionsPsoriasis
Glaxo Wellcome
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07820813
What this trial is testing

BNAbs and Anti-PD-1 in HIV

Who this might be right for
HIV-1
Ole Schmeltz Søgaard 90
Early research (Phase 1)Study completedNCT03538626
What this trial is testing

Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Who this might be right for
HIV Antibodies
National Institute of Allergy and Infectious Diseases (NIAID) 33
Early research (Phase 1)Study completedNCT04223804
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV InfectionHIV-1
AbbVie 41
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation